Eversept Partners, LP Gossamer Bio, Inc. Transaction History

Eversept Partners, LP

  • $1.32 Billion
  • Q2 2024

A detailed history of Eversept Partners, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 5,484,148 shares of GOSS stock, worth $5.43 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
5,484,148
Previous 5,994,472 8.51%
Holding current value
$5.43 Million
Previous $7.07 Million 30.23%
% of portfolio
0.37%
Previous 0.53%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.51 - $1.27 $260,265 - $648,111
-510,324 Reduced 8.51%
5,484,148 $4.94 Million
Q1 2024

May 15, 2024
SELL
$0.8 - $1.51 $350,594 - $661,746
-438,243 Reduced 6.81%
5,994,472 $7.07 Million
Q4 2023

Feb 14, 2024
BUY
$0.48 - $1.08 $962,331 - $2.17 Million
2,004,858 Added 45.28%
6,432,715 $5.85 Million
Q3 2023

Nov 14, 2023
BUY
$0.78 - $1.82 $2.87 Million - $6.69 Million
3,678,160 Added 490.62%
4,427,857 $3.68 Million
Q2 2023

Nov 08, 2023
SELL
$0.98 - $1.53 $590,320 - $921,623
-602,368 Reduced 44.55%
749,697 $899,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $590,320 - $921,623
-602,368 Reduced 44.55%
749,697 $899,000
Q1 2023

Nov 08, 2023
BUY
$0.96 - $2.92 $1.15 Million - $3.5 Million
1,197,853 Added 776.76%
1,352,065 $1.7 Million
Q1 2023

May 15, 2023
BUY
$0.96 - $2.92 $1.15 Million - $3.5 Million
1,197,853 Added 776.76%
1,352,065 $1.7 Million
Q4 2022

Nov 08, 2023
SELL
$1.74 - $12.87 $685,941 - $5.07 Million
-394,219 Reduced 71.88%
154,212 $334,000
Q4 2022

Feb 14, 2023
SELL
$1.74 - $12.87 $685,941 - $5.07 Million
-394,219 Reduced 71.88%
154,212 $334,000
Q3 2022

Nov 08, 2023
BUY
$7.21 - $14.88 $577,722 - $1.19 Million
80,128 Added 17.11%
548,431 $6.57 Million
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $577,722 - $1.19 Million
80,128 Added 17.11%
548,431 $6.57 Million
Q2 2022

Nov 08, 2023
BUY
$5.97 - $9.97 $558,672 - $932,992
93,580 Added 24.97%
468,303 $3.92 Million
Q2 2022

Aug 15, 2022
BUY
$5.97 - $9.97 $558,672 - $932,992
93,580 Added 24.97%
468,303 $3.92 Million
Q1 2022

Nov 08, 2023
SELL
$8.44 - $12.49 $3.16 Million - $4.68 Million
-374,974 Reduced 50.02%
374,723 $3.25 Million
Q1 2022

May 16, 2022
BUY
$8.44 - $12.49 $2.83 Million - $4.18 Million
334,813 Added 838.92%
374,723 $3.25 Million
Q4 2021

Nov 08, 2023
SELL
$10.12 - $14.07 $1.11 Million - $1.55 Million
-110,000 Reduced 73.38%
39,910 $451,000
Q4 2021

Feb 14, 2022
SELL
$10.12 - $14.07 $1.11 Million - $1.55 Million
-110,000 Reduced 73.38%
39,910 $451,000
Q3 2021

Nov 08, 2023
SELL
$7.25 - $13.23 $4.35 Million - $7.94 Million
-599,787 Reduced 80.0%
149,910 $1.88 Million
Q3 2021

Nov 15, 2021
BUY
$7.25 - $13.23 $1.09 Million - $1.98 Million
149,910 New
149,910 $1.88 Million

Others Institutions Holding GOSS

# of Institutions
101
Shares Held
175M
Call Options Held
453K
Put Options Held
543K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $93M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email